Dolutegravir - Latest Advances

Efficacy of Switching From Multidrug Regimens to Dolutegravir and Lamivudine in Virologically Suppressed HIV-1-Infected Individuals: A Systematic Review and Meta-Analysis.

Journal: American journal of therapeutics

Published: October 07, 2025

Persistence on dolutegravir-containing two- and three-drug-regimens in clinical practice.

Journal: International journal of STD & AIDS

Published: October 03, 2025

Elucidating the Mechanism by Which HIV-1 Nucleocapsid Mutations Confer Resistance to Integrase Strand Transfer Inhibitors.

Journal: bioRxiv : the preprint server for biology

Published: October 01, 2025

Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation.

Journal: Infectious diseases (London, England)

Published: September 22, 2025

Dolutegravir in neonates: finally we are getting there!

Journal: The lancet. HIV

Published: September 17, 2025

Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study.

Journal: medRxiv : the preprint server for health sciences

Published: September 15, 2025

Elucidating the mechanism by which HIV-1 nucleocapsid mutations confer resistance to integrase strand transfer inhibitors.

Journal: Science advances

Published: September 12, 2025

Systemic Lupus Erythematosus (SLE) Complicated by Human Immunodeficiency Virus (HIV): A Rare and Challenging Association.

Journal: Cureus

Published: September 09, 2025

Determinants of Hyperglycemia in Adult People Living With HIV Taking Dolutegravir- Based Antiretroviral Therapy at University of Gondar Hospital, North West Ethiopia, 2022: A Case-Control Study.

Journal: Journal of the International Association of Providers of AIDS Care

Published: September 09, 2025

Post-Exposure Prophylaxis: For Sexual Exposure in the LGBTQIA+ Community.

Journal: Advanced emergency nursing journal

Published: September 08, 2025

Acute rhabdomyolysis in a woman living with HIV - antiretroviral treatment is not always to blame.

Journal: International journal of STD & AIDS

Published: September 02, 2025

Total cholesterol/high-density lipoprotein cholesterol ratio is a significant predictor of metabolic syndrome among people on dolutegravir-based antiretroviral therapy: A cross-sectional study in southwestern Uganda.

Journal: The Journal of international medical research

Published: August 29, 2025

Filters

Efficacy of Switching From Multidrug Regimens to Dolutegravir and Lamivudine in Virologically Suppressed HIV-1-Infected Individuals: A Systematic Review and Meta-Analysis.

Efficacy of Switching From Multidrug Regimens to Dolutegravir and Lamivudine in Virologically Suppressed HIV-1-Infected Individuals: A Systematic Review and Meta-Analysis.

Persistence on dolutegravir-containing two- and three-drug-regimens in clinical practice.

Persistence on dolutegravir-containing two- and three-drug-regimens in clinical practice.

Elucidating the Mechanism by Which HIV-1 Nucleocapsid Mutations Confer Resistance to Integrase Strand Transfer Inhibitors.

Elucidating the Mechanism by Which HIV-1 Nucleocapsid Mutations Confer Resistance to Integrase Strand Transfer Inhibitors.

Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation.

Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation.

Dolutegravir in neonates: finally we are getting there!

Dolutegravir in neonates: finally we are getting there!

Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study.

Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study.

Elucidating the mechanism by which HIV-1 nucleocapsid mutations confer resistance to integrase strand transfer inhibitors.

Elucidating the mechanism by which HIV-1 nucleocapsid mutations confer resistance to integrase strand transfer inhibitors.

Systemic Lupus Erythematosus (SLE) Complicated by Human Immunodeficiency Virus (HIV): A Rare and Challenging Association.

Systemic Lupus Erythematosus (SLE) Complicated by Human Immunodeficiency Virus (HIV): A Rare and Challenging Association.

Determinants of Hyperglycemia in Adult People Living With HIV Taking Dolutegravir- Based Antiretroviral Therapy at University of Gondar Hospital, North West Ethiopia, 2022: A Case-Control Study.

Determinants of Hyperglycemia in Adult People Living With HIV Taking Dolutegravir- Based Antiretroviral Therapy at University of Gondar Hospital, North West Ethiopia, 2022: A Case-Control Study.

Post-Exposure Prophylaxis: For Sexual Exposure in the LGBTQIA+ Community.

Post-Exposure Prophylaxis: For Sexual Exposure in the LGBTQIA+ Community.

Acute rhabdomyolysis in a woman living with HIV - antiretroviral treatment is not always to blame.

Acute rhabdomyolysis in a woman living with HIV - antiretroviral treatment is not always to blame.

Total cholesterol/high-density lipoprotein cholesterol ratio is a significant predictor of metabolic syndrome among people on dolutegravir-based antiretroviral therapy: A cross-sectional study in southwestern Uganda.

Total cholesterol/high-density lipoprotein cholesterol ratio is a significant predictor of metabolic syndrome among people on dolutegravir-based antiretroviral therapy: A cross-sectional study in southwestern Uganda.